Portfolio company
Moleculent
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Moleculent develops a functional profiling platform and automated instruments for mapping cell-to-cell communication in human tissue to support pharmaceutical and academic researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Moleculo
Moleculo develops DNA library preparation and analysis technology for researchers to assemble short sequences into accurate, synthetic long reads.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Exciting Instruments
Exciting Instruments manufactures single-molecule fluorescence spectroscopy platforms for researchers and pharmaceutical companies to analyse molecular interactions and accelerate drug discovery.
Lightcast
Lightcast develops a microfluidic platform for single-cell functional analysis to support drug discovery and translational research for pharmaceutical companies and academic institutions.
Biomolex
This company develops digital autoradiography and molecular imaging systems for researchers performing genomic and proteomic analysis in drug discovery and precision medicine.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
RareCyte
RareCyte develops multiplexed imaging instruments and consumables for spatial biology and liquid biopsy, serving pharmaceutical companies and academic researchers in life sciences.
